1998
DOI: 10.1016/s0016-5085(98)83739-6
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism in the interleukin (IL-10) gene in patients with inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2006
2006

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Some studies demonstrated association between variant polymorphisms of metabolic enzymes and IBD: methylenetetrahydrofolate reductase C677T [53], glutathione S-transferases GSTM1 and GSTT1 [54], peroxisome proliferators-activated receptors [55], multidrug resistance 1 gene [56], IL-10 [57], keratin 8 [58], IL-4 [59], hMLH1 mismatch repair gene [60], IL-11 gene [61], TNF-α 308 [62], NF-κB1 promoter [63], p53 [64], CD14 [65], and BsmI vitamin D receptor gene in Ashkenazi Jews [66]. Whether polymorphisms in any of these genes have an influence on IBD, or serve merely as markers in LD with susceptibility genes, remains unclear.…”
Section: Bacterial Recognition Oligomerizationmentioning
confidence: 99%
See 1 more Smart Citation
“…Some studies demonstrated association between variant polymorphisms of metabolic enzymes and IBD: methylenetetrahydrofolate reductase C677T [53], glutathione S-transferases GSTM1 and GSTT1 [54], peroxisome proliferators-activated receptors [55], multidrug resistance 1 gene [56], IL-10 [57], keratin 8 [58], IL-4 [59], hMLH1 mismatch repair gene [60], IL-11 gene [61], TNF-α 308 [62], NF-κB1 promoter [63], p53 [64], CD14 [65], and BsmI vitamin D receptor gene in Ashkenazi Jews [66]. Whether polymorphisms in any of these genes have an influence on IBD, or serve merely as markers in LD with susceptibility genes, remains unclear.…”
Section: Bacterial Recognition Oligomerizationmentioning
confidence: 99%
“…Other mechanistic molecular models, such as epigenetics, may also play a role in the initiation and progression of IBD and should be explored [19]. Genomic approaches employing SNPs could facilitate the study of polymorphic variants that influence IBD or serve as markers in linkage studies [53][54][55][56][57][58][59][60][61][62][63][64][65][66]. Transcriptomic approaches could facilitate the identification of disease subgroups on the basis of gene expression signatures, and could predict disease behavior or optimal response to therapy [67][68][69][70].…”
Section: Decreased Induction/secretion Of Gstsmentioning
confidence: 99%